Top Markets
#1 Status Status +19.55%
#2 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +18.58%
#3 GoPlus Security GoPlus Security +17.93%
#4 Wrapped NXM Wrapped NXM +14.89%
#5 Bedrock Bedrock +12.87%
#6 BankrCoin BankrCoin +12.81%
#7 Ontology Gas Ontology Gas +11.52%
#8 Pons Pons +9.76%
#9 DMT-NAT DMT-NAT +8.45%
#10 Janction Janction +7.35%
Coin of the day
Status Status
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Cadrenal Therapeutics, Inc. Common Stock Cadrenal Therapeutics, Inc. Common Stock

Cadrenal Therapeutics, Inc. Common Stock

CVKD
Classifica tra le azioni #33958
Cadrenal Therapeutics, Inc. operates as a biopharmaceutical enterprise... Cadrenal Therapeutics, Inc. operates as a biopharmaceutical enterprise primarily engaged in clinical development. The company's core focus is the advancement of Tecarfarin, a novel therapeutic agent that has received orphan drug designation. This treatment is engineered to prevent systemic thromboembolism originating from cardiac issues in patients suffering from both end-stage renal disease and atrial fibrillation. Established in 2022, the firm is headquartered in Ponte Vedra, Florida.
Prezzo delle azioni
$1.83
Ultima sincronizzazione: 2026-08-14
Capitalizzazione di mercato
$6.53M
Variazione (1 giorno)
-1.61%
Variazione (1 anno)
-85.57%
Paese
US
Scambia Cadrenal Therapeutics, Inc. Common Stock (CVKD)

Categoria

Healthcare
Storico del prezzo dell'azione per Cadrenal Therapeutics, Inc. Common Stock (CVKD)
Prezzo di chiusura più alto: $1.89 il 2026-08-01

Prezzo di chiusura più basso: $46.78 il 2023-01-01
Storico del prezzo dell'azione di Cadrenal Therapeutics, Inc. Common Stock dal 2023 al 2026
Andamento annuale del prezzo dell'azione
Anno Performance
2026 (TTM) -11.31%
2025 -35.19%
2024 69.00%
2023 0.00%
Prezzo dell'azione per aziende simili o concorrenti
Azienda Prezzo dell'azione Variazione 1a% Il paese
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $505.24 28.63%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $846.09 29.41%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $731.69 6.47%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.07K -6.40%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $251.82 11.75%
BE